Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteosarcoma | 2 | 2023 | 881 | 1.150 |
Why?
|
Soft Tissue Neoplasms | 3 | 2023 | 1370 | 1.030 |
Why?
|
Fibroma, Ossifying | 1 | 2023 | 19 | 0.930 |
Why?
|
Sarcoma | 3 | 2023 | 1903 | 0.910 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2021 | 26 | 0.810 |
Why?
|
Fibroma | 1 | 2023 | 216 | 0.800 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2022 | 47 | 0.800 |
Why?
|
Cystadenoma, Papillary | 1 | 2021 | 7 | 0.800 |
Why?
|
Endometrial Hyperplasia | 1 | 2022 | 96 | 0.770 |
Why?
|
Bone Neoplasms | 2 | 2023 | 2546 | 0.720 |
Why?
|
Chondrosarcoma | 1 | 2022 | 308 | 0.680 |
Why?
|
Carcinoma, Renal Cell | 4 | 2022 | 3164 | 0.670 |
Why?
|
Carcinoma, Endometrioid | 1 | 2022 | 272 | 0.670 |
Why?
|
Neuroendocrine Tumors | 2 | 2022 | 607 | 0.660 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2021 | 1579 | 0.530 |
Why?
|
Leiomyosarcoma | 3 | 2023 | 481 | 0.480 |
Why?
|
Adenoma | 1 | 2023 | 2182 | 0.420 |
Why?
|
Endometrial Neoplasms | 1 | 2022 | 1354 | 0.420 |
Why?
|
Placenta Previa | 1 | 2024 | 123 | 0.410 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 2 | 2023 | 80 | 0.390 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1595 | 0.380 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2023 | 2039 | 0.370 |
Why?
|
Kidney Neoplasms | 3 | 2022 | 4280 | 0.360 |
Why?
|
Placenta Accreta | 1 | 2024 | 241 | 0.350 |
Why?
|
Biopsy | 4 | 2023 | 6771 | 0.350 |
Why?
|
Pancreatic Neoplasms | 2 | 2022 | 5337 | 0.290 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6387 | 0.260 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4872 | 0.240 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5751 | 0.230 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2024 | 104 | 0.220 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2023 | 153 | 0.220 |
Why?
|
Uterine Neoplasms | 2 | 2022 | 1505 | 0.220 |
Why?
|
Ileal Neoplasms | 1 | 2022 | 21 | 0.210 |
Why?
|
Leiomyomatosis | 1 | 2022 | 72 | 0.210 |
Why?
|
Mitotic Index | 1 | 2022 | 172 | 0.200 |
Why?
|
5-Methylcytosine | 1 | 2022 | 154 | 0.200 |
Why?
|
Hypertension, Portal | 1 | 2023 | 220 | 0.200 |
Why?
|
Fibromatosis, Aggressive | 1 | 2022 | 123 | 0.190 |
Why?
|
SOX9 Transcription Factor | 1 | 2022 | 147 | 0.190 |
Why?
|
Clathrin Heavy Chains | 1 | 2020 | 27 | 0.190 |
Why?
|
Pelvic Neoplasms | 1 | 2022 | 257 | 0.190 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2021 | 294 | 0.170 |
Why?
|
Immunohistochemistry | 3 | 2022 | 11395 | 0.170 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 308 | 0.160 |
Why?
|
Microscopy, Electron | 1 | 2021 | 2644 | 0.150 |
Why?
|
Leiomyoma | 1 | 2022 | 720 | 0.150 |
Why?
|
Ovary | 1 | 2021 | 983 | 0.140 |
Why?
|
Osteogenesis | 1 | 2023 | 1295 | 0.140 |
Why?
|
Point Mutation | 1 | 2021 | 1619 | 0.130 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 13042 | 0.130 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1029 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2024 | 3605 | 0.130 |
Why?
|
Femur | 1 | 2021 | 1308 | 0.130 |
Why?
|
Female | 14 | 2024 | 385090 | 0.120 |
Why?
|
Translocation, Genetic | 1 | 2020 | 1410 | 0.120 |
Why?
|
Neoplasm Invasiveness | 1 | 2023 | 3627 | 0.120 |
Why?
|
Nephrectomy | 1 | 2020 | 1046 | 0.120 |
Why?
|
Humans | 19 | 2024 | 752741 | 0.120 |
Why?
|
Kidney | 2 | 2020 | 7152 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2022 | 11091 | 0.090 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4806 | 0.090 |
Why?
|
Uterus | 1 | 2024 | 695 | 0.090 |
Why?
|
Eye | 1 | 2013 | 731 | 0.090 |
Why?
|
DNA-Binding Proteins | 2 | 2023 | 9664 | 0.080 |
Why?
|
Crohn Disease | 1 | 2022 | 2321 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3686 | 0.080 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2013 | 748 | 0.080 |
Why?
|
Cicatrix | 1 | 2024 | 774 | 0.080 |
Why?
|
Hysterectomy | 1 | 2024 | 945 | 0.080 |
Why?
|
Growth Hormone | 1 | 2010 | 706 | 0.080 |
Why?
|
Islets of Langerhans | 1 | 2013 | 1351 | 0.070 |
Why?
|
Middle Aged | 5 | 2024 | 216054 | 0.070 |
Why?
|
Leptin | 1 | 2013 | 1621 | 0.060 |
Why?
|
Prognosis | 2 | 2023 | 29264 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9305 | 0.060 |
Why?
|
Cesarean Section | 1 | 2024 | 1428 | 0.060 |
Why?
|
Placenta | 1 | 2024 | 1725 | 0.060 |
Why?
|
Immunity | 1 | 2010 | 1007 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2022 | 21904 | 0.060 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2024 | 95 | 0.060 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2023 | 74 | 0.060 |
Why?
|
Fumarate Hydratase | 1 | 2022 | 52 | 0.050 |
Why?
|
Transcription Factors | 1 | 2022 | 12165 | 0.050 |
Why?
|
Rhabdomyosarcoma | 1 | 2024 | 387 | 0.050 |
Why?
|
Ileum | 1 | 2022 | 563 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2023 | 672 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2022 | 683 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2136 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 892 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1641 | 0.040 |
Why?
|
Gene Expression | 1 | 2010 | 7771 | 0.040 |
Why?
|
Adolescent | 1 | 2023 | 86713 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1858 | 0.030 |
Why?
|
Aged | 2 | 2024 | 165629 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 64017 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2101 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 2009 | 0.030 |
Why?
|
Mice, Obese | 1 | 2013 | 426 | 0.030 |
Why?
|
Pregnancy | 1 | 2024 | 29630 | 0.030 |
Why?
|
Male | 3 | 2024 | 354311 | 0.020 |
Why?
|
Adult | 2 | 2024 | 216658 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5743 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2010 | 881 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16484 | 0.020 |
Why?
|
Child | 1 | 2024 | 78594 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2024 | 78758 | 0.020 |
Why?
|
Cattle | 1 | 2010 | 3926 | 0.020 |
Why?
|
Down-Regulation | 1 | 2010 | 2987 | 0.010 |
Why?
|
Glycoproteins | 1 | 2010 | 2253 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4194 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 23554 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40939 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 29981 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2010 | 9743 | 0.010 |
Why?
|
Mice | 2 | 2013 | 81766 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9431 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 22009 | 0.010 |
Why?
|
Animals | 2 | 2013 | 169600 | 0.010 |
Why?
|
Concepts
(118)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_